DHCR7 rs12790383: Vitamin D Levels and Genetics
The single-nucleotide polymorphism rs12790383 is located in the genomic region of the DHCR7 gene on chromosome 11. Genome-wide association studies link this marker to modest differences in baseline circulating 25-hydroxyvitamin D concentrations. Because DHCR7 regulates the metabolic crossroad between cholesterol and vitamin D synthesis, variations at this locus can influence individual nutritional biochemistry.
What each genotype means
Typical vitamin D association
This genotype is associated with baseline levels of circulating 25-hydroxyvitamin D in population studies. Research suggests that variants near the DHCR7 gene may influence the balance between cholesterol and vitamin D synthesis, though individual levels are also heavily influenced by diet and sun exposure.
This genotype is common in many global populations, though frequencies vary significantly by ancestry.
Typical vitamin D association
This genotype is associated with baseline levels of circulating 25-hydroxyvitamin D in population studies. Research suggests that variants near the DHCR7 gene may influence the balance between cholesterol and vitamin D synthesis, though individual levels are also heavily influenced by diet and sun exposure.
This genotype is common in many global populations, though frequencies vary significantly by ancestry.
Typical vitamin D association
This genotype is associated with baseline levels of circulating 25-hydroxyvitamin D in population studies. Research suggests that variants near the DHCR7 gene may influence the balance between cholesterol and vitamin D synthesis, though individual levels are also heavily influenced by diet and sun exposure.
This genotype is common in many global populations, though frequencies vary significantly by ancestry.
Genomic Location and Variant Characteristics
The single-nucleotide polymorphism rs12790383 is located on human chromosome 11, residing adjacent to the DHCR7 (7-dehydrocholesterol reductase) gene. In dbSNP, it is characterized by an adenine (A) and guanine (G) base substitution. This variant sits within a non-coding genomic region that is in linkage disequilibrium with other prominent functional markers in the DHCR7/NADSYN1 cluster, such as rs12785878. Because it does not alter the protein-coding sequence directly, scientists hypothesize that rs12790383 and its co-inherited variants act through regulatory mechanisms, such as altering transcriptional efficiency or modifying local chromatin structure. These regulatory variations can subtly tweak the expression levels of the nearby DHCR7 enzyme across tissues, including skin and liver.
The Biological Role of DHCR7
The DHCR7 gene provides instructions for producing 7-dehydrocholesterol reductase, a vital enzyme embedded in the endoplasmic reticulum membrane. This enzyme plays a central physiological role by acting as a biological switch between cholesterol biosynthesis and cutaneous vitamin D3 production. In the skin, the molecule 7-dehydrocholesterol (7-DHC) can either be converted into cholesterol by the DHCR7 enzyme or transformed into pre-vitamin D3 upon exposure to ultraviolet B (UVB) light from the sun. Therefore, reduced DHCR7 enzyme activity or lower expression allows more 7-dehydrocholesterol substrate to remain available for conversion into cholecalciferol (vitamin D3), ultimately leading to higher circulating concentrations of 25-hydroxyvitamin D [25(OH)D].
Scientific Research and Evidence Strength
Large-scale genome-wide association studies (GWAS) and meta-analyses have repeatedly identified the DHCR7 genetic locus as a significant contributor to variance in serum 25(OH)D levels. Researchers frequently use variants in this pathway, such as rs12790383 and related proxies, as instrumental variables in Mendelian randomization studies to explore causal links between vitamin D concentrations and metabolic outcomes. However, the direct clinical evidence for rs12790383 specifically is categorized as limited because common non-coding SNPs typically account for only a modest fraction (under 1-2%) of total circulating vitamin D variance. The physiological effect of this SNP is subtle, and an individual's actual vitamin D status is predominantly shaped by non-genetic factors, such as geographic latitude, seasonal sunlight, skin pigmentation, and dietary intake.
Population Patterns and Evolutionary Context
Evolutionary biologists have noted that variants near DHCR7 show distinct allele frequency distributions across global populations. Evolutionary studies using HapMap and 1000 Genomes data indicate signals of positive selection at the DHCR7 locus in ancient populations migrating to northern latitudes, where low ambient sunlight created pressure to maximize vitamin D synthesis. The minor allele at rs12790383 is relatively common, occurring at roughly 20% to 30% frequency in cohorts of European ancestry, with different distributions observed across East Asian, South Asian, and African ancestries. These divergent population frequencies reflect ancestral adaptations to regional UV radiation gradients across prehistoric human migrations.
Practical Implications for Consumers
It is critical to understand that rs12790383 is an informational trait marker, not a clinical diagnostic tool or medical screening test. Carrying alleles associated with lower 25(OH)D does not mean a person is deficient, nor does carrying higher-level alleles guarantee adequate nutritional status. No genetic test replaces standard clinical blood assays, such as a serum 25-hydroxyvitamin D lab panel ordered by a physician. Anyone considering dietary modifications, high-dose vitamin D supplementation, or managing complex metabolic conditions should consult a qualified healthcare provider or registered dietitian rather than altering their lifestyle based solely on genetic test results.
How common is this variant?
The variant rs12790383 is common globally, with an alternate allele frequency around 20% to 30% in European ancestries and varying frequencies across African, Asian, and Hispanic populations.
Frequently asked questions
Does carrying rs12790383 mean I have a vitamin D deficiency?
No. The rs12790383 variant is associated with modest baseline shifts in blood vitamin D levels in population cohorts, not clinical deficiency. Daily sunlight exposure, geographical latitude, age, and dietary habits have a far larger impact on your actual nutritional status than this single marker.
Can this genetic test replace a 25-hydroxyvitamin D blood test?
No. A genetic profile only reflects baseline biological tendencies and cannot reveal current circulating nutrient concentrations. A standard 25-hydroxyvitamin D blood test ordered by a healthcare professional is the only reliable way to check for deficiency or sufficiency.
Should I adjust my vitamin D supplement dose based on my genotype?
You should not change supplementation dosages based solely on your genotype. Dosing decisions should be guided by direct blood test results and personalized discussions with a physician or registered dietitian to avoid hypervitaminosis D or ineffective supplementation.
How does the DHCR7 gene affect vitamin D?
The DHCR7 gene encodes an enzyme that converts 7-dehydrocholesterol into cholesterol, competing directly with the pathway that converts that same molecule into vitamin D under sunlight. Changes in DHCR7 enzyme expression or activity can leave more or less raw material available to be turned into vitamin D.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs12790383?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in DHCR7
This variant (c.964-1G>C) is a pathogenic splice-site mutation associated with Smith-Lemli-Opitz syndrome, an autosomal recessive disorder of cholesterol biosynthesis.
This variant in the DHCR7 gene is involved in vitamin D synthesis and is associated with circulating 25-hydroxyvitamin D levels and potential risk for early-onset Alzheimer's disease.
This variant is a pathogenic mutation associated with carrier status for Smith-Lemli-Opitz syndrome.